Gadoxetic acid-enhanced mri surveillance

Intervention

1 paper2 findings

  • 1 lab in 1 country
  • Funder: Bayer Korea
  • Humans1

Outcomes

2

Number of surveillance examinations

downin humans1−44%

1 study
  1. Gadoxetic acid-enhanced mri surveillance decreases number of surveillance examinations in humans (-44.2%).

    Human trialcirrhosis

    Risk-stratified MRI surveillance for hepatocellular carcinoma in cirrhosis: a prospective cohort study

    European radiology15 Aug 2026

Surveillance failure

no changein humans1

1 study
  1. Gadoxetic acid-enhanced mri surveillance has no effect on surveillance failure in humans (0% (95% CI: 0-24.7%)).

    Human trialcirrhosis

    Risk-stratified MRI surveillance for hepatocellular carcinoma in cirrhosis: a prospective cohort study

    European radiology15 Aug 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 months